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Abstract
Background: Autism is a neurobehavioral spectrum of phenotypes characterized by deficits in the development of language
and social relationships and patterns of repetitive, rigid and compulsive behaviors. Twin and family studies point to a significant
genetic etiology, and several groups have performed genomic linkage screens to identify susceptibility loci.
Methods: We performed a genome-wide linkage screen in 158 combined Tufts, Vanderbilt and AGRE (Autism Genetics
Research Exchange) multiplex autism families using parametric and nonparametric methods with a categorical autism diagnosis
to identify loci of main effect. Hypothesizing interdependence of genetic risk factors prompted us to perform exploratory studies
applying the Ordered-Subset Analysis (OSA) approach using LOD scores as the trait covariate for ranking families. We
employed OSA to test for interlocus correlations between loci with LOD scores ≥1.5, and empirically determined significance
of linkage in optimal OSA subsets using permutation testing. Exploring phenotypic correlates as the basis for linkage increases
involved comparison of mean scores for quantitative trait-based subsets of autism between optimal subsets and the remaining
families.
Results: A genome-wide screen for autism loci identified the best evidence for linkage to 17q11.2 and 19p13, with maximum
multipoint heterogeneity LOD scores of 2.9 and 2.6, respectively. Suggestive linkage (LOD scores ≥1.5) at other loci included
3p, 6q, 7q, 12p, and 16p. OSA revealed positive correlations of linkage between the 19p locus and 17q, between 19p and 6q, and
between 7q and 5p. While potential phenotypic correlates for these findings were not identified for the chromosome 7/5
combination, differences indicating more rapid achievement of "developmental milestones" was apparent in the chromosome 19
OSA-defined subsets for 17q and 6q. OSA was used to test the hypothesis that 19p linkage involved more rapid achievement of
these milestones and it revealed significantly increased LOD* scores at 19p13.
Conclusions: Our results further support 19p13 as harboring an autism susceptibility locus, confirm other linkage findings at
17q11.2, and demonstrate the need to analyze more discreet trait-based subsets of complex phenotypes to improve ability to
detect genetic effects.
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Background
Autism (OMIM # 209850) is a neurobehavioral disorder
involving deficits in language and social abilities and pat-
terns of repetitive behaviors, restricted interests and resist-
ance to change. The most recent estimate of population
prevalence for the broader autism spectrum indicates a
rate of 34/10,000 (~1/300) [1], with a male: female ratio
of 4:1 [2,3]. Evidence from various studies indicates idio-
pathic autism has a complex genetic etiology. Twin stud-
ies show a concordance of 60% among monozygotic
(MZ) twins and 0% among dizygotic (DZ) pairs for classic
autism, but this increases to 92% for MZ pairs and 10%
for DZ pairs when a broader phenotype of related social
and language abnormalities is included [4,5]. The sibling
recurrence risk is suggested to be ~3–10% but may be
underestimated as a result of "stoppage rules" [6-8], and
the relative risk is thus 30–100 times that in the general
population [5,7]. Heritability is estimated at 90%, which
is among the highest for psychiatric disorders. While the
data do not strongly endorse any one model for inherit-
ance, twin and family studies support a multilocus etiol-
ogy with as many as 10–20 loci (reviewed in [9-11]).
Genome-wide screens of multiplex autism families for
susceptibility loci [12-22] have identified a few genomic
regions in common across multiple studies; 7q and 2q
have received the greatest attention [17,19,20,23-28],
with support from chromosomal abnormalities affecting
these regions in idiopathic autism (reviewed in [29]).
Genetic studies of autism are substantially complicated by
clinical and locus heterogeneity, and it is possible that epi-
static or epigenetic mechanisms may play important roles
in genetic etiology [9,30]. Analytical strategies that
address the latter concerns are limited, and most studies
to date have focused on analysis of main effects using a
global autism diagnosis to define affection status. Moving
forward, more sophisticated approaches are being pro-
posed in which trait-based subsets of the broader autism
phenotype are used in genetic analyses. Similarly, given
the interdependence of genes and their protein products
within biological systems, analytical approaches that
address potential interaction between susceptibility loci
will also be critical to characterizing gene-phenotype rela-
tionships in autism.
We report a second generation 10-cM microsatellite-based
genomic screen of multiplex autism families. The dataset
for this screen includes 71 families recruited by the Tufts/
New England Medical Center, a well-characterized set of
85 families from the Autism Genetics Resource Exchange
(AGRE), and 2 families from Vanderbilt University. Sev-
eral sites of suggestive linkage are identified, although
none meet criteria for genome-wide significance. The loci
with greatest support for linkage were 17q11.2 and
19p13; the latter site demonstrated significantly increased
allele-sharing when the Ordered-Subset Analysis (OSA)
algorithm was employed using a quantitative trait-based
autism phenotypic subset related to specific "develop-
mental milestones" as a covariate to rank families.
Methods
Sample and Demographics
The demographics for the 158 family dataset comprising
the studies in this report are shown in Table 1. Families
were recruited through three sites: (a) 71 families from the
Tufts/NEMC site, (b) 2 families from the Vanderbilt Uni-
versity site, and (c) the remainder of families (85) were
chosen from the AGRE repository based on our own
recruitment criteria. Multiplex families (mostly affected
sibling-pairs) had one affected individual who met full
criteria for autistic disorder based on Autism Diagnostic
Interview-Revised (ADI-R; [31-33])) algorithm scores,
while the second individual either met criteria or in some
cases was under the cut-off by only one or two points.
Exclusion criteria included dysmorphic features, abnor-
mal karyotype, diagnosis of fragile X syndrome, and other
genetic disorders of known etiology. Individuals were
assessed by the respective groups using the ADI-R at a
developmental age >18 months; Tufts/NEMC and Van-
derbilt groups included individuals between the ages of 4
and 22; in cases in which ADI-R interviews were per-
formed initially at <4 years, they were repeated when the
probands reached 4 years of age. All individuals were
additionally assessed using the Autism Diagnostic Obser-
vation Schedule [32,34] and the Vineland Adaptive
Behavior Scales – Interview Edition [35,36].
Genotype data and statistical analysis
DNA from Tufts and Vanderbilt samples was obtained
from peripheral blood or immortalized lymphoblastoid
cell lines using the PureGene Kit (Gentra Systems). While
a minority of families from the Tufts/NEMC cohort had
been genotyped previously [13], both new and previously
genotyped families were genotyped by deCODE (Reykja-
vik, Iceland) using their 500 marker (~8 cM intermarker
spacing) panel and corresponding genetic map [37]. Gen-
otype data were obtained from the AGRE website [38] for
families whose samples were purchased from the AGRE
repository and included in this study. Clinical procedures
and genotyping for the AGRE sample has been described
previously [18,39]. AGRE samples and corresponding
genotype data had a distinct but overlapping panel of
markers compared to the Tufts and Vanderbilt families.
AGRE genetic markers were placed on the deCODE map,
with order and spacing properly insured through exhaus-
tive comparisons between genotyped markers, available
genetic maps, and physical DNA sequence assemblies in
both public and Celera databases.BMC Medical Genetics 2005, 6:1 http://www.biomedcentral.com/1471-2350/6/1
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Genotype data for each chromosome underwent thor-
ough error detection and genotype confirmation. Initially,
data were tested for Mendelian inconsistencies using PED-
CHECK [40] and RELPAIR [41], followed by SIMWALK2
[42] for haplotype construction to detect genotyping
errors reflected by unlikely double recombinants. In the
event of a highly improbable genotype, the data for that
marker were excluded for the family.
Allele frequencies were estimated using genotype data
from all unrelated individuals in the combined dataset,
consisting of more than 300 chromosomes. Allele fre-
quencies were compared with available data from other
Caucasian populations, and no significant differences
were observed (data not shown). The LAPIS program of
the PEDIGENE system [43] was used to output appropri-
ate analysis files for the different programs.
Linkage was analyzed using both model-dependent and
model-independent methods. For autosomes, two-point
and multipoint heterogeneity LOD (HLOD) scores were
calculated under both dominant and recessive models
using Allegro [44]. Disease allele frequency was estimated
to be 0.01 and 0.1 for dominant and recessive models,
respectively. Phenotypic status was only considered for
affected individuals, and other family members were des-
ignated as having an unknown phenotypic status. Non-
parametric allele-sharing LOD* values were calculated
using affected relative pair data based on an exponential
model using the Spairs scoring function as recommended
Table 1: Sample Demographics
Families in Linkage Screen 158
Tufts/NEMC 71
AGRE 85
Vanderbilt 2
Affected Individuals 333
Males 257
Females 76
Tufts/NEMC Total 148
Males 117
Females 31
AGRE Total 181
Males 137
Females 44
Vanderbilt Total 4
Males 3
Females 1
Age at ADI (range) 2–46.7
Tufts/NEMC* 2–46.7
AGRE 2–38.0
Vanderbilt 6.2–9.2
Ethnicity (Individuals)
Caucasian (242) 73.0%
Tufts/NEMC (130) 87.8%
AGRE (108) 59.7%
Vanderbilt (4) 100.0%
Hispanic-Latino (14) 4.2%
AGRE (14) 7.7%
African-American (8) 2.4%
Tufts/NEMC (6) 4.1%
AGRE (2) 1.1%
Asian (8) 2.4%
Tufts/NEMC (2) 1.4%
AGRE (6) 3.3%
Multi-ethnic (14) 4.2%
AGRE (14) 7.7%
Other (2) 0.6%
Tufts/NEMC (2) 1.4%
Unknown (45) 13.5%
Tufts/NEMC (8) 5.4%
AGRE (37) 20.4%
I.Q. estimate distributions
Tufts/NEMC** (148)
<30 13
30–49 21
50–69 37
70+ 17
Unknown 60
AGRE*** (181)
<30 17
30–49 27
50–69 15
70+ 13
Unknown 109
Vanderbilt*** (4)
<30 1
30–49 1
50–69 0
70+ 2
Unknown 0
*ADI-Rs performed <4 yrs were repeated at 4 yrs for Tufts/NEMC 
families
**IQ estimates are based on the Vineland Daily Living standard scores
***IQ estimates are based on overall Vineland Adaptive Behavior 
standard scores
Table 1: Sample Demographics (Continued)BMC Medical Genetics 2005, 6:1 http://www.biomedcentral.com/1471-2350/6/1
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by McPeek [45]. NPL scores and corresponding P-values
were also calculated by Allegro. Data from the X chromo-
some were analyzed using ASPEX [46] and FASTLINK [47]
to calculate two-point and multipoint MLOD scores. Peak
parametric (HLOD) or nonparametric LOD* scores ≥1.5
were considered as "suggestive" evidence for linkage and
listed in Table 2, along with corresponding peak marker,
deCODE cM location, and chromosomal band position.
The nonparametric genome-wide significance threshold
[48,49] for linkage at the P = 0.05 level was determined by
conducting simulations using Merlin [50] with the current
dataset. The Simulate option in Merlin was used to pro-
duce 1000 random datasets that preserve the properties of
the original data for marker informativeness, spacing and
missing data patterns. An empirical significance threshold
was determined by using the 95th percentile of the result-
ing distribution.
OSA [51] identifies genetically more homogeneous sub-
sets of the overall data by ordering families according to
covariate trait values in ascending or descending order.
OSA takes the first family and calculates an allele-sharing
LOD* score. In an iterative process, OSA successively adds
families, re-calculating LOD* scores with each addition,
and it identifies the division in the dataset at which maxi-
mum linkage is obtained on the chromosome being ana-
lyzed. Permutation testing is used to determine the
empirical significance of the observed results. OSA has
been applied with success to identify or increase evidence
in support of linkage to complex disease susceptibility loci
[52-54].
To explore potential genetic interaction or other genetic
correlations between sites of main effect (i.e. suggestive
linkage), OSA was applied using family-specific LOD
scores as the covariate trait. Families were ranked accord-
ing to the family-specific LOD score at peak sites demon-
strating LOD scores ≥1.5. Allele-sharing analysis was
performed for the other six chromosomes using the OSA
algorithm. For instances of empirically significant
increases in evidence for linkage, we explored the nature
of the genetic correlation to ask whether it reflected clini-
cal correlations in the respective subsets. We employed
ADI-based factor subsets, identified by principal compo-
nents analyses of ADI/ADI-R items, to represent putative
phenotypic subsets in autism [55,56]. The ADI-based var-
iable clusters correspond to "(1) language, (2) social
intent, (3) developmental milestones, (4) rigid-compul-
sive behaviors, (5) savant skills, and (6) sensory aver-
sion", as determined by Folstein and colleagues [55]; and
(7) "insistence on sameness" as described by Cuccaro and
colleagues [56]. We thus compared the seven ADI-based
factor score means (both the mean of family means and
the mean of affected individuals) using a t-test for the
families above and below the OSA-determined split in the
dataset resulting in maximal linkage. Subsequent analysis
involved specific examination of the "developmental
milestones" cluster. The milestones factor indexes on the
following ADI items: "(1) To walk unaided; (2) to sit
unaided on flat surface; (3) age of first single words; (4) age of
first phrase; (5–6) acquisition of bladder control: daytime,
night; (7) acquisition of bowel control."
Analysis of the "developmental milestones" factor as a
potential phenotypic subset related to the autism linkage
correlations was performed by applying the OSA algo-
rithm. We used "developmental milestones" family
means, normalized via SAS and Box-Cox transformation
procedures, as an ascending ranking covariate. LOD*
scores were calculated according to the OSA algorithm,
and the resulting increase in linkage achieved with the
Table 2: Linkage Data for Loci with LOD Scores >1.5
Chromosome deCODE cM Marker HLOD LOD*
3p25.3 25 D3S3691 1.76R 2.22
6q23.2 131 D6S1656 1.61R 0.62
7q35 152 D7S2195 1.65R 1.14
12p12.1 45 D12S1591 1.50R 1.43
16p13.2 15 ATA41E04 1.64D 1.38
16p13.12 33 D16S3062 1.87D 1.60
16p12.3 43 D16S490 1.80D 1.49
17q11.2 53 D17S1294 2.85D 2.13
17q21.2 69 D17S1299 1.90D 1.60
19p13.11 40 D19S930 2.55R 1.92
19p13.11 56 D19S113 2.20R 1.39
R: recessive; D: dominantBMC Medical Genetics 2005, 6:1 http://www.biomedcentral.com/1471-2350/6/1
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OSA-determined family subset was analyzed through per-
mutation testing.
Approval for these studies was granted by the respective
Institutional Review Boards at Tufts University School of
Medicine/New England Medical Center and Vanderbilt
University Medical Center. Additionally, all studies were
performed with informed consent provided by the fami-
lies participating in the research.
Results
Seven chromosomes revealed one or more regions of link-
age with a model-dependent or model-independent LOD
score ≥1.5 (Figure 1). No locus reached the empirically
derived genome-wide significance level of 2.92. These sug-
gestive loci include 3p25, 6q23, 12p12, 16p12-p13,
17q11, 17q21 and 19p13 (Table 2). Data provide the
most compelling support for 17q11.2 and 19p13 as har-
boring autism susceptibility loci.
For 17q11.2, peak linkage was observed at 53 cM, corre-
sponding to marker D17S1294 (Table 2), at which we see
a multipoint HLOD of 2.85. Nonparametric multipoint
analysis revealed an allele-sharing LOD* score of 2.13 and
an NPL score of 2.84 (P = 0.0024). A second telomeric
peak can be distinguished on 17 at ~69 cM, corresponding
to 17q21.2. Marker D17S1299 at this site yielded a HLOD
of 1.9, a LOD* of 1.66 and an NPL score of 2.26 (P =
0.012). The more proximal peak at ~53 cM lies in close
proximity (~150 kb) to the serotonin transporter
(SLC6A4) locus, long considered to be an attractive func-
tional candidate gene for autism and other neuropsychiat-
ric conditions. Figure 2 shows multipoint LOD score plots
for both dominant and recessive parametric (HLOD) and
nonparametric allele-sharing LOD* values for chromo-
somes 17 and 19.
The second most significant result was observed on
19p13, where peak linkage was detected at marker
D19S930, revealing a multipoint HLOD of 2.55 at ~40 cM
(Table 2 and Figure 2). Nonparametric analyses detected
a LOD* of 1.92 and a corresponding NPL of 2.77 (P =
0.003). As with chromosome 17, the multipoint analyses
show a second more telomeric peak, corresponding to
marker D19S113. The recessive HLOD at this site was
2.20, with model-independent LOD* and NPL values of
1.39 and 2.10 (P = 0.018), respectively.
To address the possibility of gene-gene interaction, we
applied the OSA approach with family-specific LOD
scores as the ranking trait. Families, almost all of which
are affected sib-pairs, were ranked in both ascending and
descending order using family-specific LOD scores. The
three most significant correlations are presented in Figure
3. Using chromosome 19 LOD scores as the covariate, the
results on chromosome 17q, while non-significant (P =
0.1), showed an increase in linkage at the more distal peak
on 17q21.1 from a LOD* of 1.7 to 3.6 and identified an
optimal subset of 52 families. Applying the same covari-
ate, a significant increase was seen on chromosome 6q,
with a smaller, completely overlapping, 30-family opti-
mal subset. This subset resulted in an increase in LOD*
values from 1.0 to 3.6 at ~164 cM (P = 0.004). Another
significant finding involves the 7q region, possibly repre-
senting the most replicated site of linkage in autism
(reviewed in [9,29]). Given a substantial focus on this
region over several years, we lessened our criteria to exam-
ine any other chromosome demonstrating a LOD score
>1. Application of OSA using chromosome 7q linkage
data, again ranking families based on LOD scores in a
descending manner, lead to a significant increase in link-
age on 5p at ~41 cM from a LOD* of 1.1 to 3.3 in a 41-
family subset. Thus, in these three cases, notwithstanding
the nonsignificance of the 19p13/17q21 result, there is a
positive correlation of linkage in varying but overlapping
subsets of the data between these respective pair-wise
locus combinations.
To further explore the basis of the observed results, we
tested the hypothesis that underlying phenotypic
correlates might explain genetic correlations. We com-
pared the mean values for the seven factor traits in the
optimal subsets compared to the means of the remaining
families using a t-test, both under assumption of equal
and unequal variances. This comparison for all seven
available factors revealed a nominally significant differ-
ences in the chromosome 19 optimal subsets identified
from OSA analysis of chromosomes 17 (52 families) and
6 (30 families) for the "developmental milestones" clus-
ter. The families in the optimal OSA subset have lower
scores and therefore are more rapidly achieving develop-
mental milestones. A similar procedure for the chromo-
some 7-based subset revealed no obvious differences in
any of the factors (data not shown).
To directly test the hypothesis that chromosome 19 link-
age was related to reduced affection for the "developmen-
tal milestones" factor, we performed an OSA analysis in
which families were ranked in ascending order based on
mean values for the milestones factor score. Figure 2
shows the results from this analysis, which generated
increased evidence for linkage to 19p13 with peak LOD*
scores increasing from 1.9 to 3.4. Permutation testing
revealed this increase to be empirically significant (P =
0.04), thus further supporting 19p13 as harboring a
genetic risk factor for autism.
Discussion
We have presented evidence in support of autism suscep-
tibility loci on chromosomes 17q and 19p. Our resultsBMC Medical Genetics 2005, 6:1 http://www.biomedcentral.com/1471-2350/6/1
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Genome-wide nonparametric linkage analysis in 158 multiplex families for autism loci Figure 1
Genome-wide nonparametric linkage analysis in 158 multiplex families for autism loci. Individual plots show allele-
sharing LOD* scores calculated for autosomes using Allegro and MLOD scores for the X chromosome calculated using 
ASPEX.BMC Medical Genetics 2005, 6:1 http://www.biomedcentral.com/1471-2350/6/1
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suggest that the 19p locus is related to a phenotypic pro-
file involving a more rapid achievement of particular
"developmental milestones". Features indexed in this
ADI-based factor are: (1) ability to walk unaided; (2) abil-
ity to sit unaided on a flat surface; (3) age of first single
words; (4) age of first phrase; (5–6) acquisition of bladder
control: daytime and night; and (7) acquisition of bowel
control. Analyses leading to this conclusion also showed
positive genetic correlations between optimal OSA-
defined subsets contributing to linkage at 19p13 and
increases in linkage at loci on 17q21 and 6q23. A similar
positive genetic correlation was shown for chromosomes
7q and 5p, however this observation lacks evidence of an
underlying phenotypic relationship based on available
ADI variable clusters. While the increase in linkage at
17q21 was not empirically significant, the differences in
"milestone" score means between the optimal chromo-
some 19 subsets seen for both chromosomes 17 (52 fam-
ilies) and 6q (30 families) were significant. These
exploratory data led to the significant finding of increased
linkage in the single direct test of our hypothesis concern-
ing the phenotypic correlation related to chromosome 19
linkage.
Despite the significance of the final results on 19, we
remain cautious in the interpretation of the overall results.
As with a number of other genomic screens in autism, no
single main effect locus achieved genome-wide signifi-
cance. Support for a number of these loci, particularly at
17q11.2 and 19p13 comes from similar suggestive linkage
in other genomic screens for autism. Although not all
screens detect these loci (not an uncommon finding in
linkage studies for complex genetic disorders), the evi-
dence is strong regarding an effect at 19p, within 10 cM of
our peak: (1) Shao et al reported an MMLS = 1.21 and an
MLOD = 1.38 [14]; (2) the Paris Autism Research Interna-
tional Sibpair Study (PARIS) an MMLS = 1.37 [12]; the
International Molecular Genetic Study of Autism Consor-
tium (IMGSAC) reported an MLS of 1.16 [15]; the Mt.
Sinai group reported an NPL of 1.56 which increased to
2.31 when only families with obsessive-compulsive
behaviors were considered for this region [22].
Similarly, several groups have reported evidence for link-
age at 17q11. The recently published AGRE follow-up
genomic screen identified an MLS of 2.83 near SLC6A4
[21]. A genome scan for attention deficit/hyperactivity
disorder (ADHD) identified an MLS of 2.98 near this
locus [57]. An IMGSAC follow-up screen for autism [27]
reported a maximum multipoint LOD score of 2.34 at
HTTINT2 in the SLC6A4 gene on chromosome 17q11.2.
Our own more preliminary analysis of linkage in this
region with a highly overlapping dataset to that in the cur-
rent study, revealed very similar results [58]. Given our
inclusion of some AGRE families, it is not completely
unexpected that 17q11.2 linkage is similar to that seen the
larger AGRE 2nd-stage screen [21], however AGRE families
only represented about half of the overall dataset.
Families recruited from the Tufts/NEMC site are clearly
Multipoint linkage analysis under all models for chromosomes 17 (A) and 19 (B) Figure 2
Multipoint linkage analysis under all models for chromosomes 17 (A) and 19 (B). Multipoint parametric HLOD 
plots for both dominant (blue) and recessive (red) models, and nonparametric allele-sharing LOD* values (black) are displayed 
across the respective chromosomes. OSA analysis using ascending "developmental milestones" factor scores to order families 
is shown for chromosome 19, for which a 92-family optimal subset was identified and used to calculate allele-sharing LOD* 
scores (dashed black line).BMC Medical Genetics 2005, 6:1 http://www.biomedcentral.com/1471-2350/6/1
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OSA using family-specific LOD scores as the ranking covariate Figure 3
OSA using family-specific LOD scores as the ranking covariate. Families were ordered based on descending LOD 
scores at peak linkage for 19p13 and allele-sharing LOD scores calculated in the optimal subset for (A) chromosome 17 or (B) 
chromosome 6. Families were also ranked based on descending LOD scores at peak linkage on chromosome 7q (C), and LOD 
scores calculated for chromosome 5. Solid lines reflect multipoint LOD scores corresponding to the entire dataset for the 
chromosome being analyzed, while dashed lines represent analysis of the optimal subset (above the dataset division in all cases) 
identified from OSA; these were 52 families for chromosome 17, 30 for chromosome 6 and 41 families for chromosome 7.BMC Medical Genetics 2005, 6:1 http://www.biomedcentral.com/1471-2350/6/1
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contributing to this linkage based on the LOD score-based
optimal family subset compositions.
The 17q21 locus is worth further consideration. Our data
support the premise that the adjacent linkage peaks repre-
sent distinct loci and are not an artifact of primary linkage
at 17q11.2. The evidence for linkage at 17q21, while
weaker than that at 17q11.2 only 16 cM centromeric, spe-
cifically showed an, albeit nonsignificant, interlocus cor-
relation with 19p13 linkage. Linkage at 17q11.2 in this
subset of families actually decreases slightly. Of particular
interest is the fact that the distal region harbors the
integrin β3 (ITGB3) locus, which was identified recently
from a genome-wide quantitative trait locus (QTL) associ-
ation screen for platelet serotonin levels [59]. We see
nominal evidence of linkage to autism at this site, and
~20–25% of individuals with autism have elevated levels
of circulating serotonin.
The other "suggestive" (LOD ≥ 1.5) loci reported here
have also been detected in other genome-wide scans for
autism loci. A broad region of 7q has been detected in
most screens [17,20,23,25,27,28]. The 16p region has
been identified by IMGSAC, and others [15,18,22,27].
Chromosomal abnormalities have also been reported for
several of these regions in cases of autism (reviewed in
[11]). Linkage at 3p was reported by at least two groups
[14,17]. Linkage has also been reported at our 6q locus by
at least one other group [12]. Thus, while not significant,
the replication of these linkage observations provides
support for the likelihood that many of these loci repre-
sent true sites of main effect in autism.
The application of OSA to detect putative interlocus corre-
lations between the 19p13 and 17q21, 19p13 and 6q23,
and between 7q35 and 5p are limited to some degree in
significance by their highly exploratory and hypothesis-
generating nature. Given the number of comparisons
between loci, and the number of comparisons between
optimal subset pairs (on 19p or 7q) for the traits means,
the potential for type I error is increased. Therefore our
interpretation must be cast alongside appropriate caveats.
Nevertheless, the multiple exploratory comparisons gen-
erated a hypothesis: that linkage to 19p13 was related to a
more rapid achievement for specific milestones. We tested this
hypothesis with a single analysis revealing an empirically
significant increase in linkage at 19p13. Our results of
autism linkage and its increase using an ascending mile-
stone score covariate in OSA, taken in the context of rep-
licated observations of suggestive linkage by other groups,
strengthens support for the presence of an autism gene at
this site. In the end, ultimate interpretation will rely upon
replication of these phenomena with independent sam-
ples to confirm these observations.
Finally, our results highlight the utility of using trait-based
subsets of autism to identify putative susceptibility loci for
this complex disorder. We and others have hypothesized
a likely increased specificity of individual risk genes and
corresponding alleles for traits or subphenotypes com-
prising the broader autism spectrum. Therefore methods
such as OSA with power to identify more homogeneous
samples and QTL (quantitative trait locus) linkage and
association analyses should provide greater sensitivity in
the discovery of disease genes in the context of locus and
clinical heterogeneity. Additionally, OSA or other forms
of conditional linkage analyses, have the ability to
uncover potential interactions between loci, an important
concept since the inherent interdependence of proteins in
common pathways or networks acting during
development and normal neuronal function could be eas-
ily imagined to act genetically in concert with one
another.
Conclusions
We report evidence to support linkage of autism to
17p11.2 and 19p13. Exploratory analyses to test for corre-
lations between suggestively-linked loci, using the OSA
method revealed positive correlations of linkage (i.e. in
overlapping families) between 7q and 5p, 19p and 6q,
and possibly 19p and 17q22, distal to peak linkage at
17q11.2. Comparing mean scores for ADI-derived factor
traits from families above and below the OSA-defined
split maximizing linkage, suggested a positive correlation
between 19p13 linkage and a more rapid achievement of
"developmental milestones" as measured by items in this
cluster of ADI variables. We tested this hypothesis by
applying OSA with descending "developmental mile-
stone" scores as the ranking covariate, and detected an
empirically-significant increase in linkage to 19p13. These
findings further support evidence for an autism suscepti-
bility locus in 19p13 and underscore the utility in apply-
ing trait subsets in complex disorders to identify genetic
risk factors.
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